QIAGEN Revenue 2010-2022 | QGEN
QIAGEN annual/quarterly revenue history and growth rate from 2010 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- QIAGEN revenue for the quarter ending September 30, 2022 was $0.500B, a 6.57% decline year-over-year.
- QIAGEN revenue for the twelve months ending September 30, 2022 was $2.226B, a 0.65% decline year-over-year.
- QIAGEN annual revenue for 2021 was $2.252B, a 20.39% increase from 2020.
- QIAGEN annual revenue for 2020 was $1.87B, a 22.53% increase from 2019.
- QIAGEN annual revenue for 2019 was $1.526B, a 1.64% increase from 2018.
QIAGEN Annual Revenue
(Millions of US $) |
| 2021 |
$2,252 |
| 2020 |
$1,870 |
| 2019 |
$1,526 |
| 2018 |
$1,502 |
| 2017 |
$1,418 |
| 2016 |
$1,338 |
| 2015 |
$1,281 |
| 2014 |
$1,345 |
| 2013 |
$1,302 |
| 2012 |
$1,254 |
| 2011 |
$1,170 |
| 2010 |
$1,087 |
| 2009 |
$1,010 |
QIAGEN Quarterly Revenue
(Millions of US $) |
| 2022-09-30 |
$500 |
| 2022-06-30 |
$516 |
| 2022-03-31 |
$628 |
| 2021-12-31 |
$582 |
| 2021-09-30 |
$535 |
| 2021-06-30 |
$567 |
| 2021-03-31 |
$567 |
| 2020-12-31 |
$571 |
| 2020-09-30 |
$484 |
| 2020-06-30 |
$443 |
| 2020-03-31 |
$372 |
| 2019-12-31 |
$413 |
| 2019-09-30 |
$383 |
| 2019-06-30 |
$382 |
| 2019-03-31 |
$349 |
| 2018-12-31 |
$403 |
| 2018-09-30 |
$378 |
| 2018-06-30 |
$377 |
| 2018-03-31 |
$344 |
| 2017-12-31 |
$397 |
| 2017-09-30 |
$364 |
| 2017-06-30 |
$349 |
| 2017-03-31 |
$308 |
| 2016-12-31 |
$367 |
| 2016-09-30 |
$339 |
| 2016-06-30 |
$334 |
| 2016-03-31 |
$298 |
| 2015-12-31 |
$349 |
| 2015-09-30 |
$315 |
| 2015-06-30 |
$319 |
| 2015-03-31 |
$298 |
| 2014-12-31 |
$360 |
| 2014-09-30 |
$336 |
| 2014-06-30 |
$331 |
| 2014-03-31 |
$317 |
| 2013-12-31 |
$361 |
| 2013-09-30 |
$322 |
| 2013-06-30 |
$315 |
| 2013-03-31 |
$304 |
| 2012-12-31 |
$347 |
| 2012-09-30 |
$304 |
| 2012-06-30 |
$307 |
| 2012-03-31 |
$296 |
| 2011-12-31 |
$334 |
| 2011-09-30 |
$289 |
| 2011-06-30 |
$282 |
| 2011-03-31 |
$264 |
| 2010-12-31 |
$286 |
| 2010-09-30 |
$274 |
| 2010-06-30 |
$263 |
| 2010-03-31 |
$264 |
| 2009-12-31 |
$289 |
| 2009-09-30 |
$260 |
| 2009-06-30 |
$240 |
| 2009-03-31 |
$221 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$11.197B |
$2.252B |
|
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
|
